Knowing that intra-individual laboratory Hb concentration variability is ± 0.5 g/dL and that fluctuations of volemia (weight gain and weight loss) may significantly affect the precision of Hb measurements, this suggest that our ANN model provides a clinically-acceptable tool for guiding anemia management in HD patients. This evidence concerns the gene GSTM1 and anemia.